Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

GBT Picks Up Inclacumab From Roche's Bargain Bin

Aug 24 2018

• By Kevin Grogan

Shopping cart — GBT picks up Roche drug for a snip • Source: Shutterstock

Related Content

Emmaus Plans Modest Pricing In 4Q Rollout Of Sickle Cell Drug Endari

Jul 10 2017

Sierra Believes It Can Do Better Than Gilead With JAK Inhibitor Momelotinib

Aug 24 2018

Global Blood Makes Case For Accelerated Approval Of Sickle Cell Drug Voxelotor

Jun 28 2018

Novartis Buys Selexys As Competitors Stumble In Sickle Cell

Nov 21 2016

Next steps unclear as Roche's inclacumab meets Phase II endpoint in post-angioplasty study

Mar 12 2013

Related Companies

Roche Holding AG

Gilead Sciences, Inc.

Global Blood Therapeutics, Inc.

Genmab A/S

Emmaus Life Sciences, Inc.

Novartis AG

Sierra Oncology, Inc.

Additional Topics

Deals Commercial Cardiovascular BioPharmaceutical

More from Cardiovascular

More from Therapy Areas

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window